Table 1 Main characteristics of the included studies.
Study | Year | Sample size | R0 resection | Recurrence in R0 resection | R1 resection | Recurrence in R1 resection | Adjuvant imatinib treatment | Survival analysis | Outcomes | Follow-up (median, range) | Quality score |
|---|---|---|---|---|---|---|---|---|---|---|---|
Cananzi et al. | 2014 | 92 | 86 | 31 | 6 | 2 | Yes | Kaplan–Meier | DFS, OS | 41, 2–145 months | 7 |
Jakob et al. | 2013 | 36 | 24 | 3 | 12 | 4 | Yes | Kaplan–Meier | DFS, OS | 41, 3–110 months | 7 |
McCarter et al. | 2012 | 817 | 745 | 204 | 72 | 26 | Yes | Kaplan–Meier | DFS | 49 months | 8 |
Kim et al. | 2012 | 136 | 122 | 5 | 14 | 0 | No | Kaplan–Meier | DFS | 29, 3–106 months | 7 |
Huang et al. | 2012 | 85 | 82 | NR | 3 | NR | Yes | Kaplan–Meier | DFS, OS | 41, 3–100 months | 7 |
Catena et al. | 2012 | 151 | 132 | 71 | 19 | 6 | No | Cox regression | DFS | 101, 11–132 months | 7 |
Nikfarjam et al. | 2008 | 40 | 35 | NR | 5 | NR | Yes | Kaplan–Meier | DFS, OS | 24, 1–74 months | 7 |
Gouveia et al. | 2008 | 96 | 78 | 7 | 18 | 5 | No | Cox regression | DFS, OS | 42, 1–206 months | 7 |
Rutkowski et al. | 2007 | 328 | 253 | 151 | 75 | 29 | No | Cox regression | DFS | 31, 4–292 months | 7 |
Wu et al. | 2006 | 85 | 81 | NR | 4 | NR | No | Cox regression | DFS, OS | 33, 5–202 months | 7 |
Pierie et al. | 2001 | 39 | 35 | 13 | 4 | 3 | No | Cox regression | DFS, OS | 38, 1–159 months | 7 |
DeMatteo et al. | 2000 | 80 | 65 | NR | 15 | NR | No | Kaplan–Meier | OS | 24, 1–175 months | 7 |
